Terns Pharmaceuticals Inc

TERN NASDAQ Santé & Biotech États-Unis US8808811074
52.95 $

Terns Pharmaceuticals est spécialisée dans la recherche et le développement de thérapies en hépatologie, notamment pour le traitement de la NASH.

Performance & Momentum

6 Months 32.71 %
1 Year 1 257 %
3 Years 351.02 %
5 Years 239.42 %

Similar stocks to Terns Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Terns Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases